Amal Therapeutics is a startup based in Switzerland, 1 tracked investor.
Amal Therapeutics is a company headquartered in Switzerland. Brouky records 1 investor associated with the company.
Amal Therapeutics is a Swiss biotechnology company developing therapeutic cancer vaccines and immunotherapies, using proprietary peptide-based platforms to elicit tumor-specific T cell responses for oncology indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.